Skip to main content

News

head uk2

Press releases

Here you can access to all press releases published by Heppe Medical Chitosan GmbH.

 

Press release mRNA active ingredients: Protected for an optimized effect

Berlin, Halle, 16.03.2023: Since January of this year, the project "Zielwirk" is developing a new chitosan technology for the efficient release of mRNA active ingredients. The technology aims to ensure that drugs for the treatment of serious diseases can be better absorbed as well as processed by the body. The participating project partners Heppe Medical Chitosan GmbH, FDX Fluid Dynamix GmbH, Martin Luther University Halle-Wittenberg and the Fraunhofer Institute for Production Systems and Design Technology (IPK) are funded by the German Federal Ministry of Economics and Climate Protection (BMWK) with six million euros over three years.

drug delivery, chitosan, nanoparticles

HMC as a founding member of the new cluster initiative Life-Science Saxony-Anhalt

On November 16, 2022 the supporting association of the new cluster initiative Life-Science Saxony-Anhalt was founded in the technology park Weinberg Campus. We, the Heppe Medical Chitosan GmbH, are excited to be part of it as a founding member.

Weinberg Campus, Life Science

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.